We are live on ! Find out more
IQMD

Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD

Delisted

IQMD was delisted on the 26th of April, 2023.

Back to rankings

60 hedge funds and large institutions have $197M invested in Intelligent Medicine Acquisition Corp. Class A Common Stock in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 7

22% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 9

22% more capital invested

Capital invested by funds: $161M → $197M (+$35.7M)

3% more funds holding

Funds holding: 58 → 60 (+2)

Holders
60
Holders Change
+2
Holders Change %
+3.45%
% of All Funds
0.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
11
Reduced
9
Closed
7
Calls
$103K
Puts
–
Net Calls
+$103K
Net Calls Change
+$2K

Top Buyers

Rank Fund Capital Flow
1
Calamos Advisors
Calamos Advisors
Illinois
+$12.7M
2
HIM
HGC Investment Management
Ontario, Canada
+$8.13M
3
CC
Centiva Capital
New York
+$6.3M
4
CCA
Castle Creek Arbitrage
Colorado
+$4.06M
5
KIM
Karpus Investment Management
New York
+$2.22M

Top Sellers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
-$3.85M
2
PC
Periscope Capital
Ontario, Canada
-$1.61M
3
SC
Sculptor Capital
New York
-$1.03M
4
WAM
Weiss Asset Management
Massachusetts
-$762K
5
BCM
Basso Capital Management
Connecticut
-$557K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
26
Tenor Capital Management
New York
$2.57M – – –
Hudson Bay Capital Management
27
Hudson Bay Capital Management
Connecticut
$2.57M – – –
KIM
28
Karpus Investment Management
New York
$2.25M +$2.22M +218,661 New
DFCM
29
Dark Forest Capital Management
Puerto Rico
$2.13M +$2.1M +207,060 New
PMAM
30
Picton Mahoney Asset Management
Ontario, Canada
$2.09M – – –
Goldman Sachs
31
Goldman Sachs
New York
$2.08M – – –
AIMCA
32
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$2.06M – – –
WA
33
Whitebox Advisors
Minnesota
$2.06M – – –
LP
34
LMR Partners
United Kingdom
$2.06M +$2.03M +200,000 New
WAM
35
Weiss Asset Management
Massachusetts
$1.71M -$762K -75,000 -31%
CCM
36
Context Capital Management
California
$1.39M – – –
CH
37
CVI Holdings
Delaware
$1.16M -$75.5K -7,432 -6%
SV
38
Starboard Value
New York
$1.1M – – –
Walleye Capital
39
Walleye Capital
New York
$1.06M – – –
DKCM
40
Davidson Kempner Capital Management
New York
$1.03M – – –
OCM
41
Oaktree Capital Management
California
$1.03M – – –
DCM
42
Difesa Capital Management
New York
$1.03M +$1.02M +100,000 New
WAM
43
Wolverine Asset Management
Illinois
$661K -$153K -15,047 -19%
Walleye Trading
44
Walleye Trading
New York
$648K – – –
DAM
45
DLD Asset Management
New York
$479K +$34.3K +3,375 +8%
LA
46
Linden Advisors
New York
$462K – – –
EC
47
Elequin Capital
New York
$458K +$438K +43,140 +3,081%
BFM
48
Boothbay Fund Management
New York
$446K +$108K +10,608 +32%
RL
49
RPO LLC
Connecticut
$371K +$367K +36,083 New
LCM
50
Lynwood Capital Management
Ontario, Canada
$324K – – –
1
2
3

IQMD Hedge Fund Activity: Q4 2022 in Review

60 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) for Q4 2022, worth a combined $197M — up 22% from $161M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new IQMD positions and 7 closed out — a net gain of 2 holders — while 11 added to existing stakes and 9 trimmed.

The largest buyer was Calamos Advisors, opening a new position worth an estimated $12.7M. The largest seller was UBS O'Connor, exiting entirely with an estimated $3.85M sold.

  • 60 institutional investors held Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) as of Q4 2022, up from 58 in Q3 2022.
  • Funds reported $197M of Intelligent Medicine Acquisition Corp. Class A Common Stock stock for Q4 2022, up 22% quarter-over-quarter.
  • 9 funds opened new Intelligent Medicine Acquisition Corp. Class A Common Stock positions in Q4 2022 and 7 closed out, a net change of +2 holders.
  • The largest Intelligent Medicine Acquisition Corp. Class A Common Stock buyer in Q4 2022 was Calamos Advisors, an estimated $12.7M added.
  • The largest Intelligent Medicine Acquisition Corp. Class A Common Stock seller in Q4 2022 was UBS O'Connor, an estimated $3.85M sold.

Based on aggregated 13F filings for Q4 2022.